• Call Us! 786.749.1221

  • NASDAQ: SMFL $2.35

Smart for Life Releases CEO Statement on Successful Recapitalization

Smart for Life Releases CEO Statement on Successful Recapitalization

Smart for Life Releases CEO Statement on Successful Recapitalization 700 394 Smart for Life, Inc.

Proceeds to Accelerate Revenue Growth Through Sales Initiatives and Additional Product Launches

Transformative Event Includes Conversion of Approximately $6 Million of Debt into Equity, $4.5 Million of Warrant Conversions and Conversion of $1.2 Million of Accrued Compensation by Management and the Board of Directors

Miami, FL – May 31, 2023 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced the release of a video statement by Darren Minton, CEO of Smart for Life, regarding the company’s successful initiatives as it refinances its capital structure, enhances its balance sheet and utilizes the proceeds to accelerate revenue growth.

These initiatives include the Company’s previously announced conversion of approximately $6 million of debt into equity, as well as over $1.2 million of deferred compensation for Smart for Life’s executive management team and the Company’s board of directors into equity under the same terms. More specifically, the aforementioned conversions are being made into the Company’s Series B preferred stock, par value $0.0001 per share, that is convertible into common stock at an exercise price of $2.23 per share. Lastly, more than 3.5 million shares of warrant conversions have been exercised, resulting in gross proceeds in excess of $4.5 million for Smart for Life.

“Our management team and board of directors are excited to announce this successful reorganization of our capital structure and achieving a significant transformation of our balance sheet,” stated Darren Minton, CEO of Smart for Life. “Not only does this include conversion of $6 million of debt to equity and $1.2 million of deferred compensation by the executive management team and board of directors that we previously announced on Friday, but we also announced warrant exercises, resulting in a cash infusion of over $4.5 million into Smart for Life. We believe these major milestones further support our Nasdaq listing, as well as position Smart for Life for significant growth over the coming weeks and months with additional product launches and sales activity. We look forward to providing additional updates shortly on our exciting operational achievements and further news on our M&A developments in short order.”

The video statement featuring Smart for Life’s CEO Darren Minton can be found here:
www.smartforlifecorp.com/2023/05/29/video-smfl-ceo-darren-minton/.

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on health and wellness. Structured as a publicly held global holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues by the fourth quarter of 2026. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Video regarding the Company’s manufacturing facility at Bonne Santé Natural Manufacturing is available at: www.bonnesantemanufacturing.com/video.

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com